It currently takes over 10 years and $1.3B to develop a drug. More than 70% of that investment goes into clinical trials, yet only ~10% of candidates make it from Phase I to approval. Evinova a new health-tech business is here to change the math. We use advanced algorithms and GenAI to aim high: boosting clinical trial success by 20% , cutting development time by 3 years , and halving study costs. We are looking for a highly skilled Senior Principal AI Consultant who combines strong business ac…